Economic Evaluation in Clinical Trials - 22-24 June 2011
Venue: University of Glasgow
A 3-day computer-based course
This course is a collaboration between Health Economics and Health Technology Assessment, Centre for Population and Health Sciences, University of Glasgow and researchers in the Division of General Internal Medicine at the University of Pennsylvania
The course is designed for individuals undertaking health economic evaluations in academia, consultancies and industry, as well as those involved in the design and analysis of clinical trials (statisticians and health service researchers).
By the end of the course, participants will be able to:
* Design an economic evaluation in a clinical trial appropriate to a setting or intervention(s), including multinational RCTs
* Analyse cost and effect data using univariate and multivariate approaches
* Estimate cost effectiveness (and net benefit) and the uncertainty surrounding the estimate
* Consider issues of transferability
The course will start with designing a multinational trial and consider the issues of evaluating data from such a trial (what data to collect, how to value cost and effect, how to analyse the data, and estimate cost effectiveness) as building blocks over the three days.
Specific exercises will be conducted to illustrate the effect of distributional assumptions, univariate and multivariable approaches for the analysis of costs and QALYs, sample size and power calculations and their interpretation, reporting sampling uncertainty for the comparison of cost and effects.
Software and prerequisites
This is course focuses specifically on the analysis of cost and effect data in an economic evaluation alongside a clinical trial. Participants are expected to be familiar with t-tests and ordinary least squares regression. Familiarity with sample size calculation for clinical outcomes will be helpful but not required.
The course will be 'hands-on', and participants are required to bring a laptop computer (and mouse). The course will use STATA and enrolled participants who do not have STATA will be provided with a temporary STATA licence. Familiarity with STATA is not necessary, but will be beneficial.
The statistical modules will involve computer work on exercises which will be built up over the three days. In addition, participants will be given the opportunity to bring along their own evaluations for further development during the course.
* Andrew Briggs, DPhil, Public Health and Health Policy, University of Glasgow. Andrew Briggs was appointed to the Lindsay Chair in Health Policy and Economic Evaluation in June 2005. Andrew has an interest in all aspects of economic evaluation applied to health care, in particular the use of statistical methods for assessing cost and cost-effectiveness, and the use of risk/prognostic modelling for making treatment decisions and guiding policy. More details are available here <http://www.gla.ac.uk/departments/publichealth/ourstaff/andybriggs/> .
* Henry Glick, PhD, Division of General Internal Medicine and Leonard Davis Institute of Health Economics, University of Pennsylvania. Henry has more than 20 years of experience in conducting economic assessments of medical therapies. He specializes in economic assessments conducted as part of clinical trials. In addition, he has extensive experience with decision analysis, preference assessment, analysis of observational data, and the evaluation of diagnostic tests. More details are available here <http://www.uphs.upenn.edu/dgimhsr/henryglick.htm> .
* Jalpa Doshi, PhD, Division of General Internal Medicine and Leonard Davis Institute of Health Economics, University of Pennsylvania. Jalpa's research interests revolve around economic and outcomes assessments of medication use and adherence using observational as well as randomised trial data. She has extensive experience conducting evaluations using Medicare, Medicaid, VA and commercial insurance
* datasets. More details are available here <http://www.uphs.upenn.edu/dgimhsr/jd.htm> .
The Glasgow course will take place on the University of Glasgow campus. This is situated in the lively West End of the City with many shops, bars and restaurants. It is also only a short underground trip away from the City Centre. The course is non-residential. Limited accommodation will be available at a reduced rate at the Hilton Glasgow Grovesnor on a first come first served basis, some accommodation may be available on campus but there are also lots of hotels and bed & breakfast accommodation within walking distance.
A map showing the locations of some hotels in the West End and the City Centre is available from Anne Marie McLean at [log in to unmask] More details about accommodation and a hotel booking service are available from the University of Glasgow's Conference & Visitor Services Office <http://www.cvso.co.uk/services/cvso/accommodation/hotelbookingservice/> .
Travel directions, a University map and information about Glasgow University is available from the University website <http://www.gla.ac.uk/about/maps/>
Please contact Anne Marie McLean, Centre for Population and Health Sciences, University of Glasgow on 0141 330 5518 or e-mail [log in to unmask] for more information.
* 2011 fees
* Public/academic £950
Commercial sector £1,480
* Fees are fully inclusive of tuition, lunch, course dinner, and course materials but do not include accommodation. VAT is not payable.
Anne Marie McLean
Tel: +44(141) 330 5518
Fax: +44(141) 330 5018
email: [log in to unmask]
Centre for Population and Health Sciences
College of Medical, Veterinary and Life Sciences
University of Glasgow
1 Lilybank Gardens
The University of Glasgow charity number is SC004401
You may leave the list at any time by sending the command
to [log in to unmask], leaving the subject line blank.